Preclinical Study of a Dual-Target Molecular Probe Labeled with <sup>68</sup>Ga Targeting SSTR2 and FAP
Objective: Currently, <sup>68</sup>Ga-labeled somatostatin analogs (SSAs) are the most commonly used imaging agents for patients with neuroendocrine tumors (NETs) in clinical practice, demonstrating good results in tumor diagnosis. For applications in peptide receptor radionuclide therap...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/12/1647 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|